RESTASIS Trademark

Trademark Overview

On Wednesday, January 3, 2001, a trademark application was filed for RESTASIS with the United States Patent and Trademark Office. The USPTO has given the RESTASIS trademark a serial number of 78041554. The federal status of this trademark filing is REGISTERED AND RENEWED as of Tuesday, February 14, 2023. This trademark is owned by Allergan, Inc.. The RESTASIS trademark is filed in the Pharmaceutical Products category with the following description:

Topical ophthalmic pharmaceutical products for the treatment of dryness of the eye
restasis

General Information

Serial Number78041554
Word MarkRESTASIS
Filing DateWednesday, January 3, 2001
Status800 - REGISTERED AND RENEWED
Status DateTuesday, February 14, 2023
Registration Number2738873
Registration DateTuesday, July 15, 2003
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 21, 2001

Trademark Statements

Goods and ServicesTopical ophthalmic pharmaceutical products for the treatment of dryness of the eye

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 17, 2001
Primary Code005
First Use Anywhere DateWednesday, October 29, 1997
First Use In Commerce DateTuesday, April 1, 2003

Trademark Owner History

Party NameAllergan, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNorth Chicago, IL 60064
Party NameAllergan, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIrvine, CA 92612
Party NameAllergan, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92612

Trademark Events

Event DateEvent Description
Tuesday, February 14, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Tuesday, February 14, 2023REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Tuesday, February 14, 2023REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Monday, February 13, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, July 27, 2022TEAS SECTION 8 & 9 RECEIVED
Friday, July 15, 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Saturday, February 23, 2013NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Friday, February 22, 2013REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Friday, February 22, 2013REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Friday, February 22, 2013CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, February 6, 2013TEAS SECTION 8 & 9 RECEIVED
Wednesday, February 6, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 28, 2008REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, August 19, 2008ASSIGNED TO PARALEGAL
Tuesday, August 12, 2008TEAS SECTION 8 & 15 RECEIVED
Tuesday, May 27, 2008CASE FILE IN TICRS
Tuesday, July 15, 2003REGISTERED-PRINCIPAL REGISTER
Tuesday, May 6, 2003ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, May 5, 2003ASSIGNED TO EXAMINER
Thursday, May 1, 2003STATEMENT OF USE PROCESSING COMPLETE
Tuesday, April 15, 2003USE AMENDMENT FILED
Tuesday, April 15, 2003TEAS STATEMENT OF USE RECEIVED
Tuesday, December 3, 2002SOU EXTENSION 2 GRANTED
Thursday, September 19, 2002SOU EXTENSION 2 FILED
Thursday, September 19, 2002TEAS EXTENSION RECEIVED
Thursday, February 28, 2002SOU EXTENSION 1 GRANTED
Thursday, February 14, 2002SOU EXTENSION 1 FILED
Tuesday, November 13, 2001NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 21, 2001PUBLISHED FOR OPPOSITION
Wednesday, August 1, 2001NOTICE OF PUBLICATION
Saturday, June 2, 2001APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 24, 2001ASSIGNED TO EXAMINER

Related Keywords

restasis treatment dryness products pharmaceutical ophthalmic topical